Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander hoofdstuk

2022 | OriginalPaper | Hoofdstuk

19. Diabetes

Auteurs: prof. dr. Guy Rutten, dr. Rimke Vos

Gepubliceerd in: Gendersensitieve huisartsgeneeskunde

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Diabetes is de meest voorkomende chronische ziekte in de huisartspraktijk; in een doorsnee huisartspraktijk gaat het om ongeveer 130 mensen. Een ongezonde leefstijl verhoogt bij vrouwen in sterkere mate dan bij mannen het risico op het krijgen van type 2 diabetes. Diabetes verhoogt het risico van vrouwen op het ontwikkelen van hart- en vaatziekten met 30–50 %. Er zijn aanwijzingen dat huisartsen dit risico bij vrouwen onderschatten; om dit tegen te gaan kunnen ze gebruikmaken van interactieve calculators, zoals U-Prevent. Vooral in de eerste lijn komt polyfarmacie vaker voor bij vrouwen met diabetes dan bij mannen met diabetes. Er zijn aanwijzingen dat Nederlandse mannen minder vaak dan vrouwen zelf verantwoordelijkheid willen nemen voor hun diabetes, alhoewel ze vaker geneigd zijn om medicatie te nemen om alle behandeldoelen onder controle te krijgen. Mannen en vrouwen gedragen zich nauwelijks verschillend binnen de Nederlandse diabeteszorg, al maken mannen waarschijnlijk vaker gebruik van een patiëntenportaal als die mogelijkheid bestaat.
Literatuur
1.
go back to reference Huebschmann AG, et al. Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course. Diabetologia. 2019;(62):1–12. Huebschmann AG, et al. Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course. Diabetologia. 2019;(62):1–12.
2.
go back to reference Logue J, Walker JJ, Colhoun HM, Leese GP, Lindsay RS, McKnight JA, et al. Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia. 2011;54(12):3003–6. CrossRef Logue J, Walker JJ, Colhoun HM, Leese GP, Lindsay RS, McKnight JA, et al. Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia. 2011;54(12):3003–6. CrossRef
3.
go back to reference Wright AK, Welsh P, Gill JMR, Kontopantelis E, Emsley R, Buchan I, Ashcroft DM, Rutter MK, Sattar N. Age-, sex- and ethnicity-related differences in body weight, blood pressure, HbA(1c) and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetes. Diabetologia. 2020;63(8):1542–53. CrossRef Wright AK, Welsh P, Gill JMR, Kontopantelis E, Emsley R, Buchan I, Ashcroft DM, Rutter MK, Sattar N. Age-, sex- and ethnicity-related differences in body weight, blood pressure, HbA(1c) and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetes. Diabetologia. 2020;63(8):1542–53. CrossRef
4.
go back to reference Norberg M, Stenlund H, Lindahl B, Andersson C, Eriksson JW, Weinehall L. Work stress and low emotional support is associated with increased risk of future type 2 diabetes in women. Diabetes Res Clin Pract. 2007;76(3):368–77. CrossRef Norberg M, Stenlund H, Lindahl B, Andersson C, Eriksson JW, Weinehall L. Work stress and low emotional support is associated with increased risk of future type 2 diabetes in women. Diabetes Res Clin Pract. 2007;76(3):368–77. CrossRef
5.
go back to reference Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008;31(12):2383–90. CrossRef Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008;31(12):2383–90. CrossRef
6.
go back to reference Mauvais-Jarvis F, Bairey Merz NB, Barnes PJ, Brinton RD, Carrero JJ, DeMeo DL, et al. Sex and gender: modifiers of health, disease and medicine. Lancet. 2020;396:565–82. CrossRef Mauvais-Jarvis F, Bairey Merz NB, Barnes PJ, Brinton RD, Carrero JJ, DeMeo DL, et al. Sex and gender: modifiers of health, disease and medicine. Lancet. 2020;396:565–82. CrossRef
7.
go back to reference Wermeling PR, Gorter KJ, Van der Stel HF, Rutten GEHM. Both cardiovascular and non-cardiovascular comorbidity are related to health status in well-controlled type 2 diabetes patients: a cross-sectional analysis. Cardiovasc Diabetol. 2012;11:121. CrossRef Wermeling PR, Gorter KJ, Van der Stel HF, Rutten GEHM. Both cardiovascular and non-cardiovascular comorbidity are related to health status in well-controlled type 2 diabetes patients: a cross-sectional analysis. Cardiovasc Diabetol. 2012;11:121. CrossRef
8.
go back to reference Look AHEAD Research Group. Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145–54. CrossRef Look AHEAD Research Group. Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145–54. CrossRef
9.
go back to reference Peters SA, Huxley RR, Sattar N, Woodward M, Sex differences in the excess risk of cardiovascular diseases associated with type 2 diabetes: potential explanations and clinical implications. Curr Cardiovasc Risk Rep. 2015;9(7):36. Peters SA, Huxley RR, Sattar N, Woodward M, Sex differences in the excess risk of cardiovascular diseases associated with type 2 diabetes: potential explanations and clinical implications. Curr Cardiovasc Risk Rep. 2015;9(7):36.
10.
go back to reference De Jong M, Woodward M, Peters SAE. Diabetes, glycated hemoglobin, and the risk of myocardial infarction in women and men: a prospective cohort study of the UK biobank. Diabetes Care. 2020;43:2050–9. CrossRef De Jong M, Woodward M, Peters SAE. Diabetes, glycated hemoglobin, and the risk of myocardial infarction in women and men: a prospective cohort study of the UK biobank. Diabetes Care. 2020;43:2050–9. CrossRef
11.
go back to reference De Ritter R, De Jong M (both authors contributed equally), Vos RC; Van der Kallen CJH, Sep SJS, Woodward M, Stehouwer CDA, Bots ML, Peters SAE. Sex differences in the risk of vascular disease associated with diabetes. Biol Sex Differ. 2020;11(1):1. De Ritter R, De Jong M (both authors contributed equally), Vos RC; Van der Kallen CJH, Sep SJS, Woodward M, Stehouwer CDA, Bots ML, Peters SAE. Sex differences in the risk of vascular disease associated with diabetes. Biol Sex Differ. 2020;11(1):1.
12.
go back to reference De Jong M, Peters SAE, De Ritter R, Van der Kallen CJH, Sep SJS, Woodward M, Stehouwer CDA, Bots ML, Vos RC. Sex Disparities in Cardiovascular Risk Factor Assessment and Screening for Diabetes-Related Complications in Individuals With Diabetes: A Systematic Review. Front Endocrinol (Lausanne). 2021 Mar 30;12:617902. doi: https://​doi.​org/​10.​3389/​fendo.​2021.​617902. De Jong M, Peters SAE, De Ritter R, Van der Kallen CJH, Sep SJS, Woodward M, Stehouwer CDA, Bots ML, Vos RC. Sex Disparities in Cardiovascular Risk Factor Assessment and Screening for Diabetes-Related Complications in Individuals With Diabetes: A Systematic Review. Front Endocrinol (Lausanne). 2021 Mar 30;12:617902. doi: https://​doi.​org/​10.​3389/​fendo.​2021.​617902.
13.
go back to reference Stol DM, Hollander M, Damman OC, Nielen MM, Badenbroek I, Schellevis FG, et al. Mismatch between self-perceived and calculated cardiometabolic disease risk among participants in a prevention program for cardiometabolic disease: a cross-sectional study. BMC Public Health. 2020;20(1):740. CrossRef Stol DM, Hollander M, Damman OC, Nielen MM, Badenbroek I, Schellevis FG, et al. Mismatch between self-perceived and calculated cardiometabolic disease risk among participants in a prevention program for cardiometabolic disease: a cross-sectional study. BMC Public Health. 2020;20(1):740. CrossRef
14.
go back to reference Wind AE, Gorter KJ, Van den Donk M, Rutten GEHM. Impact of UKPDS risk estimation added to a first subjective risk estimation on management of coronary heart disease risk in type 2 diabetes – an observational study. Prim Care Diab. 2016;10(1):27–35. CrossRef Wind AE, Gorter KJ, Van den Donk M, Rutten GEHM. Impact of UKPDS risk estimation added to a first subjective risk estimation on management of coronary heart disease risk in type 2 diabetes – an observational study. Prim Care Diab. 2016;10(1):27–35. CrossRef
15.
go back to reference Beulens JWJ, Hart HE, Kuijs R, Kooijman-Buiting AMJ, Rutten GEHM. Influence of duration and dose of methformin on cobalamin deficiency in type 2 diabetes patients using methformin. Acta Diabetol. 2015;52(1):47–53. Beulens JWJ, Hart HE, Kuijs R, Kooijman-Buiting AMJ, Rutten GEHM. Influence of duration and dose of methformin on cobalamin deficiency in type 2 diabetes patients using methformin. Acta Diabetol. 2015;52(1):47–53.
16.
go back to reference Biemans E, Hart HE, Rutten GEHM, Cuellar Renteria VG, Kooijman-Buiting AMJ, Beulens JWJ. Cobalamin status and its relation with depression, cognition and neuropathy in patients with type 2 diabetes mellitus using metformin. Acta Diabetol. 2015;52(2):383–93. CrossRef Biemans E, Hart HE, Rutten GEHM, Cuellar Renteria VG, Kooijman-Buiting AMJ, Beulens JWJ. Cobalamin status and its relation with depression, cognition and neuropathy in patients with type 2 diabetes mellitus using metformin. Acta Diabetol. 2015;52(2):383–93. CrossRef
17.
go back to reference Gouni-Berthold I, Berthold HK, Mantzoros C, Böhm M, Krone W. Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes. Diabetes Care. 2008;31:1389–91. CrossRef Gouni-Berthold I, Berthold HK, Mantzoros C, Böhm M, Krone W. Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes. Diabetes Care. 2008;31:1389–91. CrossRef
18.
go back to reference Kasteleyn M, Wezendonk A, Vos RC, Numans ME, Jansen H, Rutten GEHM. Repeat prescriptions of guideline-based secondary prevention in patients with type 2 diabetes and previous myocardial infarction in Dutch primary care. Fam Pract. 2014;31(6):688–93. CrossRef Kasteleyn M, Wezendonk A, Vos RC, Numans ME, Jansen H, Rutten GEHM. Repeat prescriptions of guideline-based secondary prevention in patients with type 2 diabetes and previous myocardial infarction in Dutch primary care. Fam Pract. 2014;31(6):688–93. CrossRef
20.
go back to reference Kasteleyn MJ, De Vries L, Van Puffelen AL, Schellevis FG, Rijken M, Vos RC, Rutten GE. Diabetes-related distress over the course of illness: results from the Diacourse study. Diabet Med. 2015;32(12):1617–24. CrossRef Kasteleyn MJ, De Vries L, Van Puffelen AL, Schellevis FG, Rijken M, Vos RC, Rutten GE. Diabetes-related distress over the course of illness: results from the Diacourse study. Diabet Med. 2015;32(12):1617–24. CrossRef
21.
go back to reference Kasteleyn MJ, Vos RC, Rijken M, Schellevis FG, Rutten GE. Effectiveness of tailored support for people with Type 2 diabetes after a first acute coronary event: a multicentre randomized controlled trial (the Diacourse-ACE study). Diabet Med. 2016;33(1):125–33. CrossRef Kasteleyn MJ, Vos RC, Rijken M, Schellevis FG, Rutten GE. Effectiveness of tailored support for people with Type 2 diabetes after a first acute coronary event: a multicentre randomized controlled trial (the Diacourse-ACE study). Diabet Med. 2016;33(1):125–33. CrossRef
22.
go back to reference Gorter KJ, Tuytel GJ, De Leeuw RR, Bensing JM, Rutten GE. Opinions of patients with type 2 diabetes about responsibility, setting targets and willingness to take medication. A cross-sectional survey. Patient Educ Couns. 2011 Jul;84(1):56–61. CrossRef Gorter KJ, Tuytel GJ, De Leeuw RR, Bensing JM, Rutten GE. Opinions of patients with type 2 diabetes about responsibility, setting targets and willingness to take medication. A cross-sectional survey. Patient Educ Couns. 2011 Jul;84(1):56–61. CrossRef
23.
go back to reference Gorter KJ, Tuytel GH, De Leeuw JRJ, Van der Bijl JJ, Bensing JM, Rutten GEHM. Preferences and opinions of patients with type 2 diabetes on education and self-care: a cross-sectional survey. Diabet Med. 2010;27(1):85–91. CrossRef Gorter KJ, Tuytel GH, De Leeuw JRJ, Van der Bijl JJ, Bensing JM, Rutten GEHM. Preferences and opinions of patients with type 2 diabetes on education and self-care: a cross-sectional survey. Diabet Med. 2010;27(1):85–91. CrossRef
24.
go back to reference Vitale M, Masulli M, Cocozza S, Anichini R, Babini AC, Boemi M. Sex differences in food choices, adherence to dietary recommendations and plasma lipid profile in type 2 diabetes–the TOSCA. IT study. Nutrition, Metabolism and Cardiovascular Diseases. 2016;26(10):879–85. Vitale M, Masulli M, Cocozza S, Anichini R, Babini AC, Boemi M. Sex differences in food choices, adherence to dietary recommendations and plasma lipid profile in type 2 diabetes–the TOSCA. IT study. Nutrition, Metabolism and Cardiovascular Diseases. 2016;26(10):879–85.
25.
go back to reference Jansen H, Den Engelsen C, Rutten GEHM. Physical activity in patients with metabolic syndrome: at screening and three years thereafter. Metab Syndr Relat Disord. 2013;11(3):163–8. CrossRef Jansen H, Den Engelsen C, Rutten GEHM. Physical activity in patients with metabolic syndrome: at screening and three years thereafter. Metab Syndr Relat Disord. 2013;11(3):163–8. CrossRef
26.
go back to reference Den Engelsen C, Vos RC, Rijken M, Rutten GEHM. Comparison of perceptions of obesity among adults with central obesity with and without additional cardiometabolic risk factors and among those who were formally obese, 3 years after screening for central obesity. BMC Public Health. 2015;15:1214. CrossRef Den Engelsen C, Vos RC, Rijken M, Rutten GEHM. Comparison of perceptions of obesity among adults with central obesity with and without additional cardiometabolic risk factors and among those who were formally obese, 3 years after screening for central obesity. BMC Public Health. 2015;15:1214. CrossRef
27.
go back to reference Boels AM, Vos RC, Hermans TGT, Zuithoff NPA, Müller N, Khunti K, Rutten GEHM; GUIDANCE study group. What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries. BMJ Open. 2017 Jul 11;7(7):e016180. Boels AM, Vos RC, Hermans TGT, Zuithoff NPA, Müller N, Khunti K, Rutten GEHM; GUIDANCE study group. What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries. BMJ Open. 2017 Jul 11;7(7):e016180.
28.
go back to reference Wermeling PR, Janssen J, Gorter K, Beulens JWJ, Rutten GEHM. Satisfaction of well-controlled type 2 diabetes patients with three-monthly and six-monthly monitoring. BMC Fam Pract. 2013;14:107. CrossRef Wermeling PR, Janssen J, Gorter K, Beulens JWJ, Rutten GEHM. Satisfaction of well-controlled type 2 diabetes patients with three-monthly and six-monthly monitoring. BMC Fam Pract. 2013;14:107. CrossRef
29.
go back to reference Van Vugt HA, Heijmans MJWM, De Koning EJP, Rutten GEHM. Factors that influence the intended intensity of diabetes care in a person-centred setting. Diab Med. 2020;37:1167–75. CrossRef Van Vugt HA, Heijmans MJWM, De Koning EJP, Rutten GEHM. Factors that influence the intended intensity of diabetes care in a person-centred setting. Diab Med. 2020;37:1167–75. CrossRef
30.
go back to reference Ronda MC, Dijkhorst-Oei LT, Gorter KJ, Beulens JW, Rutten GE. Differences between diabetes patients who are interested or not in the use of a patient Web portal. Diabetes Technol Ther. 2013;15(7):556–63. CrossRef Ronda MC, Dijkhorst-Oei LT, Gorter KJ, Beulens JW, Rutten GE. Differences between diabetes patients who are interested or not in the use of a patient Web portal. Diabetes Technol Ther. 2013;15(7):556–63. CrossRef
Metagegevens
Titel
Diabetes
Auteurs
prof. dr. Guy Rutten
dr. Rimke Vos
Copyright
2022
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-2707-2_19